Biography

Dr Metcalf is a Medical Oncologist and Clinician Scientist treating patients with Head and Neck Cancers with an academic focus on Salivary Gland Cancers.

Dr Metcalf was awarded his Medical Degree (MBChB) at the University of Manchester in 2004, during which he was awarded a First Class BSc in Health Care Ethics and Law. He became a Member of the Royal College of Physicians (UK) in 2007 and completed Medical Oncology Higher Specialist training in 2015.

Following his Medical Oncology Specialist Training, he was awarded a PhD 2012 - 2016, following a Clinical Fellowship in the Clinical and Experimental Pharmacology Lab led by Prof Caroline Dive C.B.E. at the Cancer Research UK Manchester Institute. During his time studying circulating tumour cells as a 'liquid biopsy', he contributed to the development of new pre-clinical models of lung cancer.

Following the award of his PhD, Dr Metcalf undertook post-doctoral research in tumour-immunology in Head and Neck Cancers based in the Manchester Collaborative Centre for Inflammatory Research under Prof Tracy Hussell. He is now the U.K. lead for Salivary Gland Cancer through the International Rare Cancers Initiative, a joint initiative through Cancer Research UK, EORTC and the US National Cancer Institute.

His current clinical practice is a research practice embedded in both the Head and Neck Cancer Team and the Experimental Cancer Medicine Team at one of Europe's Largest Cancer Hospitals, The Christie NHS in Manchester, U.K..

Since 2017 he has been supported through Academic Grants from the Manchester Cancer Research Centre (which comprises funding through Cancer Research UK, The University of Manchester and The Christie NHS) and the US based Adenoid Cystic Carcinoma Research Foundation and philanthropic grants from the Infrastructure Industry Foundation, Syncona Foundation, The Christie Charity as well as through donations by patients and their friends and families. His current research funding administered through the Christie Charity is the Ella Project, in memory of one of his patients who was instrumental in establishing the UK research program into Adenoid Cystic Carcinoma. He has also previously been awarded the prestigious University of Manchester Dean's Prize for Clinicians on two occasions which funded both his academic and clinical time and additional research costs to develop his leadership role in Salivary Gland Cancer Research.